DK1527197T3 - Association af EDG5-polymorfi V286A med type II diabetes mellitus og venös trombose/lungeemboli og anvendelse deraf - Google Patents

Association af EDG5-polymorfi V286A med type II diabetes mellitus og venös trombose/lungeemboli og anvendelse deraf

Info

Publication number
DK1527197T3
DK1527197T3 DK03729923T DK03729923T DK1527197T3 DK 1527197 T3 DK1527197 T3 DK 1527197T3 DK 03729923 T DK03729923 T DK 03729923T DK 03729923 T DK03729923 T DK 03729923T DK 1527197 T3 DK1527197 T3 DK 1527197T3
Authority
DK
Denmark
Prior art keywords
type
diabetes mellitus
pulmonary embolism
venous thrombosis
association
Prior art date
Application number
DK03729923T
Other languages
Danish (da)
English (en)
Inventor
Sylvain Ricard
Evi Kostenis
Karl-Ernst Siegler
Jean-Francois Deleuze
Sandrine Mace
Detlef Kozian
Martina Jacobs
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Application granted granted Critical
Publication of DK1527197T3 publication Critical patent/DK1527197T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK03729923T 2002-04-09 2003-04-07 Association af EDG5-polymorfi V286A med type II diabetes mellitus og venös trombose/lungeemboli og anvendelse deraf DK1527197T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02007879 2002-04-09
PCT/EP2003/003569 WO2003085130A1 (en) 2002-04-09 2003-04-07 Association of edg5 polymorphism v286a with type ii diabetes mellitus and venous thrombosis/pulmonary embolism and the use thereof

Publications (1)

Publication Number Publication Date
DK1527197T3 true DK1527197T3 (da) 2008-10-20

Family

ID=28685845

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03729923T DK1527197T3 (da) 2002-04-09 2003-04-07 Association af EDG5-polymorfi V286A med type II diabetes mellitus og venös trombose/lungeemboli og anvendelse deraf

Country Status (12)

Country Link
EP (1) EP1527197B1 (el)
JP (2) JP4284194B2 (el)
AT (1) ATE398684T1 (el)
AU (1) AU2003240449A1 (el)
CA (1) CA2481300A1 (el)
CY (1) CY1108340T1 (el)
DE (1) DE60321684D1 (el)
DK (1) DK1527197T3 (el)
ES (1) ES2307938T3 (el)
PT (1) PT1527197E (el)
SI (1) SI1527197T1 (el)
WO (1) WO2003085130A1 (el)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6579516B1 (en) 1995-06-13 2003-06-17 Zahra Mansouri Methods of delivering materials into the skin, and compositions used therein
US20130236893A1 (en) * 2010-09-02 2013-09-12 Tokushukai Method of detecting type ii diabetes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057126A (en) * 1997-12-24 2000-05-02 Allelix Biopharmaceuticals, Inc. Mammalian EDG-5 receptor homologs
EP1071708A4 (en) * 1998-04-23 2005-01-19 Smithkline Beecham Corp GENE OF THE EDG FAMILY, HUMAN H218

Also Published As

Publication number Publication date
JP4956565B2 (ja) 2012-06-20
AU2003240449A1 (en) 2003-10-20
PT1527197E (pt) 2008-09-22
SI1527197T1 (sl) 2008-10-31
JP2005522199A (ja) 2005-07-28
CA2481300A1 (en) 2003-10-16
ATE398684T1 (de) 2008-07-15
JP4284194B2 (ja) 2009-06-24
DE60321684D1 (de) 2008-07-31
EP1527197B1 (en) 2008-06-18
WO2003085130A1 (en) 2003-10-16
ES2307938T3 (es) 2008-12-01
JP2009171971A (ja) 2009-08-06
CY1108340T1 (el) 2014-02-12
EP1527197A1 (en) 2005-05-04

Similar Documents

Publication Publication Date Title
DK1092155T3 (da) Fremgangsmåde til tidlig diagnose af carcinomer
ATE532070T1 (de) Entzündungsmarker zum nachweis und zur prävention von diabetes mellitus
DK1351707T3 (da) Fremgangsmåder til behandling af autoimmunsygdomme hos et individ og in vitro-diagnostiske analyser
DE69937835D1 (de) Antikörper für apoptosemarker und anwendungsverfahren
ATE278960T1 (de) Verbessertes immundiagnostische tests durch verwendung von reduzierende agenzien
DK1336109T3 (da) Kit og fremgangsmåde til at påvise proteinet EMS-1
ATE466020T1 (de) Neue isoform des gefässendothelzell wachstumshemmers (vegi)
DE60335726D1 (de) Chromoprotein und fluoroproteine
NO964022L (no) -2-antichymotrypsinanaloger med elastasehemmende aktivitet
DK1276763T3 (da) Anti-fryseproteiner, deres fremstilling og anvendelse
DK1400589T3 (da) Fremgangsmåde til påvisning af prokaryotisk DNA
DK1527197T3 (da) Association af EDG5-polymorfi V286A med type II diabetes mellitus og venös trombose/lungeemboli og anvendelse deraf
EP1780215A4 (en) MORBUS CROHN ANTIBODY PEPPTH PEPTIDE AND REAGENT TO TEST MORBUS CROHN
ATE549404T1 (de) Verfahren zum screening eines transmembranenzymhemmstoffs
DE60035267D1 (de) Verfahren zur analyse der menge an intraabdominalem fettgewebe
ITTO20000674A0 (it) Composizioni a base di aminoacidi, atte al trattamento dell'insufficienza cardiaca.
DE60136573D1 (de) Gewebefixativzusammensetzung
TW200720656A (en) Prediction of prognosis of liver disease associated with hepatitis c virus infection
NO20081503L (no) T-celle adhesjonsmolekyl, og antistoff dertil
ATE348840T1 (de) Verfahren zur prävention einer durch gefrieren induzierten abnahme der aktivität eines proteins
ATE281522T1 (de) Sentrin-spezifische menschliche protease senp1
ATE447045T1 (de) Assoziation von proteinpolymorphismen mit koronarer herzkrankheit
DE60321443D1 (de) Screening-verfahren für eine prophylaktische und therapeutische Substanz für eine Nierenerkrankung
HUP0104954A2 (hu) A PRV-1 gén és felhasználása
SE0202608D0 (sv) New sequences